Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10283893" target="_blank" >RIV/00216208:11110/14:10283893 - isvavai.cz</a>
Alternative codes found
RIV/60456540:_____/14:#0000693 RIV/00023728:_____/14:#0004016
Result on the web
<a href="http://dx.doi.org/10.1371/journal.pone.0103495" target="_blank" >http://dx.doi.org/10.1371/journal.pone.0103495</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1371/journal.pone.0103495" target="_blank" >10.1371/journal.pone.0103495</a>

Result language
angličtina
Original language name
Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort
Original language description
In this study we found that serum visfatin was significantly elevated in early RA patients compared to healthy controls and significantly decreased after three months of treatment. Circulating visfatin and a change in visfatin level correlated with disease activity and improved disease activity over time. Furthermore, a decrease in visfatin after three months predicted disease activity improvement after 12 months
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—

Project
<a href="/en/project/NT13696" target="_blank" >NT13696: The application of visfatin analysis in the study of predictive relevance and efficacy of pharmacological intervention in patients with rheumatoid arthritis</a><br>
Continuities
S - Specificky vyzkum na vysokych skolach

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)